Informações:
Falhas:
Palavras-chave
Infecções por HIV ×
- Clinical Trial (55)
- Clinical Trial, Phase IV (36)
- Herpes Genitalis (36)
- Clinical Trial, Phase III (26)
- Pneumococcal Vaccines (26)
- HIV (26)
- Eligibility Determination (16)
- Virology (12)
- Hematologic Tests (11)
- Adverse event (8)
- Communicable Diseases (8)
- Vaccination (7)
- Recurrence (6)
- Case Reports (4)
- Common Data Elements (CDE) (4)
- Clinical Laboratory Services (3)
- Demography (3)
- Informed Consent (3)
- Laboratories (3)
- Neurology (3)
- Physical Examination (2)
- Central Nervous System Neoplasms (2)
- Brain Neoplasms (2)
- Concomitant Medication (2)
- End of Study (2)
- Hypersensitivity (2)
- Medical History Taking (2)
- Poliovirus Vaccine, Oral (1)
- Pregnancy Tests (1)
- Random Allocation (1)
- Reference Values (1)
- Spinal Puncture (1)
- BCG Vaccine (1)
- Drugs, Investigational (1)
- Comorbidity (1)
- Urinalysis (1)
- Hepatitis B Vaccines (1)
- Hepatitis C, Chronic (1)
- Breast Feeding (1)
- Consent Forms (1)
- Vital Signs (1)
- On-Study Form (1)
- PRO (1)
- Patient Reported Outcome (PRO) (1)
- Treatment Form (1)
- Off-Treatment (1)
- Compliance (1)
- Drug Therapy (1)
- Hematology (1)
- Immunization, Secondary (1)
- Measles Vaccine (1)
- Meningitis (1)
- Microbiology (1)
Índice
Modelos de dados selecionados
Deve ter sessão iniciada para selecionar vários modelos de dados e para os transferir ou analisar.
86 Resultados da pesquisa.
Grupos de itens: Study administration, HEMATOLOGY, CLINICAL CHEMISTRY
Grupos de itens: Study administration, HEMATOLOGY, CLINICAL CHEMISTRY
Grupos de itens: Administrative documentation, Clinical HIV staging, HIV infection WHO clinical stage 1, HIV infection WHO clinical stage 2, HIV infection WHO clinical stage 3, HIV infection WHO clinical stage 4
Grupos de itens: Study administration, SERIOUS ADVERSE EVENTS, SERIOUS ADVERSE EVENTS, Seriousness, Demography Data, INSTRUCTIONS FOR COMPLETING SERIOUS ADVERSE EVENT FORMS, Possible Causes of SAE Other Than lnvestigational Products, RELEVANT Medical Conditions, Other RELEVANT Risk Factors, RELEVANT Concomitant Medications, Details of lnvestigational Products, Details of RELEVANT Assessments, Narrative Remarks
Grupo de itens: Demographics
Grupos de itens: Inclusion Criteria, Exclusion Criteria
Grupos de itens: Inclusion Criteria, Exclusion Criteria
Grupos de itens: Inclusion Criteria, Exclusion Criteria
Grupos de itens: Inclusion Criteria, Exclusion Criteria
Grupos de itens: Inclusion Criteria, Exclusion Criteria
Grupos de itens: Inclusion Criteria, Exclusion Criteria
Grupos de itens: Inclusion Criteria, Exclusion Criteria